CCEL
CRYO CELL INTERNATIONAL INCCompany Information
- Company Name
- CRYO CELL INTERNATIONAL INC
- CIK
- CIK0000862692
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CCEL: NYSE
- Fiscal Year End
- November 30
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8090
- SIC Description
- Services-Misc Health & Allied Services, NEC
- Ticker
- CCEL
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-09-18
- Last sale
- 2022-11-15
- Shares purchased (TTM)
- 31,378
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 532,695
- Shares outstanding
- 8,055,150
- Ownership
- 6.61%
Earnings Market Reaction
- Filing date
- 2026-07-15
- Price on filing date
- —
- 1-month reaction
- 0.56%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | ||||||
| Marketable Securities Current | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | ||||||
| Accounts Receivable Net Current | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | ||||||
| Prepaid Expense Current | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Inventory Net | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Current | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Derivative Fair Value Of Derivative Asset | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 11 | 11 | 12 | 12 | 13 | 13 | 13 | 11 | 10 | 9 | 9 | 10 | ||||||
| Property Plant And Equipment Net | 21 | 21 | 21 | 21 | 21 | 22 | 22 | 22 | 22 | 22 | 21 | 19 | ||||||
Long Term Investments And Receivables Net | ||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Inventory Noncurrent | 1 | 1 | 1 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 9 | ||||||
| Goodwill | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Deferred Income Tax Assets Net | 24 | 24 | 24 | 21 | 21 | 21 | 21 | 20 | 20 | 20 | 20 | 14 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Noncurrent | 29 | 29 | 29 | 30 | 30 | 30 | 30 | 30 | 30 | 31 | 31 | 41 | ||||||
| Assets | 61 | 61 | 62 | 63 | 64 | 64 | 65 | 63 | 63 | 62 | 61 | 70 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | ||||||
| Accrued Liabilities Current | 3 | 3 | 4 | 2 | 3 | 4 | 6 | 3 | 3 | 4 | 5 | 2 | ||||||
| Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Lines Of Credit Current | 0 | 2 | 2 | 3 | 7 | 5 | 4 | 2 | 4 | 2 | 1 | 3 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Contract With Customer Liability Current | 9 | 9 | 10 | 10 | 10 | 9 | 10 | 10 | 10 | 9 | 10 | 10 | ||||||
| Liabilities Current | 16 | 18 | 20 | 18 | 22 | 22 | 22 | 17 | 19 | 19 | 21 | 19 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Contract With Customer Liability Noncurrent | 53 | 52 | 51 | 50 | 49 | 48 | 47 | 45 | 44 | 43 | 41 | 40 | ||||||
| Long Term Notes Payable | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Long Term Debt Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Sundry Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Other Liabilities Noncurrent | 63 | 62 | 61 | 60 | 58 | 57 | 56 | 55 | 54 | 53 | 51 | 51 | ||||||
| Liabilities | 78 | 79 | 80 | 78 | 80 | 79 | 78 | 72 | 73 | 72 | 72 | 70 | ||||||
| Commitments And Contingencies | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 45 | 45 | 45 | 45 | 45 | 45 | 44 | 44 | 44 | 44 | 43 | 43 | ||||||
| Treasury Stock Value | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -24 | -23 | -23 | ||||||
| Retained Earnings Accumulated Deficit | -38 | -38 | -38 | -35 | -35 | -35 | -33 | -29 | -30 | -31 | -31 | -20 | ||||||
| Stockholders Equity | -18 | -18 | -19 | -15 | -16 | -15 | -13 | -10 | -11 | -10 | -11 | -0 | ||||||
| Liabilities And Stockholders Equity | 61 | 61 | 62 | 63 | 64 | 64 | 65 | 63 | 63 | 62 | 61 | 70 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Common Stock Shares Issued | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | ||||||
| Shares Outstanding | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCRYO CELL INTERNATIONAL INC (CCEL) — SEC Financial Statements & Analysis
CRYO CELL INTERNATIONAL INC (CCEL) is a services-misc health & allied services, nec company, incorporated in DE. CRYO CELL INTERNATIONAL INC trades on NYSE as: CCEL. CRYO CELL INTERNATIONAL INC (CCEL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-05-31, filed with the SEC on 2026-07-15. Based on that filing, CRYO CELL INTERNATIONAL INC carries a market cap of $27.15M, a P/E ratio of -11.01x, a P/B ratio of -1.53x, a P/S ratio of 0.87x, an enterprise value of $34.92M, and an EV/EBITDA multiple of 40.08x. On profitability, it posts a gross margin of 77.93%, an operating margin of -0.33%, a net margin of -7.92%, a Return on Equity (ROE) of 14.81%, a Return on Assets (ROA) of -3.94%, and a Return on Invested Capital (ROIC) of -145.37%. Per share, it reports EPS of $-0.31, diluted EPS of $-0.31, free cash flow per share of $0.76, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -2.69% year-over-year, net income growth of 1339.81% year-over-year, and EPS growth of 1344.22% year-over-year. On the balance sheet, it maintains a current ratio of 0.71x, a quick ratio of 0.66x, working capital of $-4.63M, a debt-to-equity ratio of -4.42x, a debt ratio of 1.29, an interest coverage ratio of -0.05x, free cash flow of $6.11M (TTM), and net debt of $7.77M. Figures sourced from SEC EDGAR.
- Market Cap
- $27.15M
- P/E TTM
- -11.01x
- EPS TTM
- $-0.31
- P/B TTM
- -1.53x
- ROE TTM
- 14.81%
- ROA TTM
- -3.94%
- Debt To Equity
- -4.42x
- Free Cash Flow TTM
- $6.11M
- Net Revenue TTM Growth 1Y
- -2.69%
Data as of 2026-05-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CRYO CELL INTERNATIONAL INC in?
CRYO CELL INTERNATIONAL INC (CCEL) operates in the Services-Misc Health & Allied Services, NEC industry.
What exchange does CCEL trade on?
CRYO CELL INTERNATIONAL INC (CCEL) trades on the NYSE.
Where is CRYO CELL INTERNATIONAL INC incorporated?
CRYO CELL INTERNATIONAL INC is incorporated in DE.
When was CRYO CELL INTERNATIONAL INC (CCEL)'s most recent SEC filing?
CRYO CELL INTERNATIONAL INC (CCEL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-05-31, filed with the SEC on 2026-07-15.
What is CCEL's market cap?
CRYO CELL INTERNATIONAL INC (CCEL) has a market capitalization of $27.15M as of 2026-05-31.
What is CCEL's EPS (earnings per share)?
CRYO CELL INTERNATIONAL INC (CCEL)'s trailing twelve month EPS is $-0.31 as of 2026-05-31.
What is CCEL's ROE (return on equity)?
CRYO CELL INTERNATIONAL INC (CCEL)'s trailing twelve month Return on Equity (ROE) is 14.81% as of 2026-05-31.
What is CCEL's ROA (return on assets)?
CRYO CELL INTERNATIONAL INC (CCEL)'s trailing twelve month Return on Assets (ROA) is -3.94% as of 2026-05-31.
What is CCEL's ROIC (return on invested capital)?
CRYO CELL INTERNATIONAL INC (CCEL)'s trailing twelve month Return on Invested Capital (ROIC) is -145.37% as of 2024-08-31.
What is CCEL's EV/EBITDA?
CRYO CELL INTERNATIONAL INC (CCEL)'s trailing twelve month EV/EBITDA is 40.08x as of 2026-05-31.